Welcome to the CRPS Ketamine Center
The CRPS Ketamine Center offers specialized treatment using intravenous ketamine for patients with Complex regional pain syndrome (CRPS). The Center was founded by Dr. Charles Chaney with the aim of providing rapid and effective treatment for CRPS. Patients are seen in the Newport Beach location or the Costa Mesa location for initial evaluation, and ketamine infusions are performed in the safe and controlled setting of a hospital at College Hospital in Costa Mesa.
We at the CRPS Ketamine Center are dedicated to eradicating the pain caused by CRPS, and improving the lives of those suffering from this condition. We hope to allow each patient the ability to find joy and live life to the fullest again. We aim to achieve this using safe protocols in the hands of professional doctors, nurses, and pharmacy staff.
Our Main Office
The CRPS Ketamine Center provides intravenous ketamine to patients with CRPS who are appropriate for this treatment. Our main office is located in Newport Beach in Southern California. Dr. Chaney also sees patients for initial visits at College Hospital in Costa Mesa. Placebo-controlled studies have shown both topical and intravenous administration of ketamine to be effective at alleviating pain and inducing complete remission in treatment resistant patients, thereby highlighting the potential of this approach (1-4).
At this time, the Center does not provide intranasal ketamine or oral ketamine because these routes have not been shown to be as effective as IV for alleviating CRPS pain. Most recent studies have looked at intravenous ketamine for the treatment of CRPS pain. Our ketamine location offers free parking and a very experienced staff of nurses, pharmacists, and doctors.
Our Ketamine Location
The CRPS Ketamine Center provides intravenous ketamine to patients with CRPS who are appropriate for this treatment. All ketamine infusions take place in the controlled setting of hospital only 6 minutes away from our Newport Beach office at College Hospital Costa Mesa.
Placebo-controlled studies have shown both topical and intravenous administration of ketamine to be effective at alleviating pain and inducing complete remission in treatment resistant patients, thereby highlighting the potential of this approach (1-4). At this time, the Center does not provide intranasal ketamine or oral ketamine because these routes have not been shown to be as effective as IV for alleviating CRPS pain. The vast majority of research has looked at intravenous ketamine in the treatment of CRPS pain.
Dr. Chaney is a leader in CRPS medicine. He trained at and graduated from the prestigious UC San Diego Pain Medicine Fellowship, which was the recipient of the American Academy of Pain Medicine (AAPM) 2019 Pain Medicine Fellowship Excellence Award. Dr. Chaney trained under Dr. Mark Wallace who is the chair of the Division of Pain Medicine within UC San Diego School of Medicine’s Department of Anesthesiology and has co-authored 119 peer-reviewed articles and five books on pain medicine. Dr. Chaney completed various stages of his medical training at Northwestern University Feinberg School of Medicine, UCLA, and UCSD. He is dedicated to treating Complex regional pain syndrome.
1. Kiefer RT, Rohr P, Ploppa A, Dieterich HJ, Grothusen J, Koffler S, et al. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med. 2008;9(8):1173–1201. doi: 10.1111/j.1526-4637.2007.00402.x.
2. Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009;147(1–3):107–115. doi: 10.1016/j.pain.2009.08.015.
3. Sigtermans MJ, van Hilten JJ, Bauer MC, Arbous MS, Marinus J, Sarton EY, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009;145(3):304–311. doi: 10.1016/j.pain.2009.06.023.
4. Finch PM, Knudsen L, Drummond PD. Reduction of allodynia in patients with complex regional pain syndrome: a double-blind placebo-controlled trial of topical ketamine. Pain. 2009;146(1–2):18–25. doi: 10.1016/j.pain.2009.05.017.